ข่าวฟอเร็กซ์
Quest PharmaTech names Jeffrey Shon CEO for Nov. 23
Quest PharmaTech said Jeffrey Shon will become CEO on November 23, 2026, as Dr. Madi Madiyalakan retires that day.
โดย Kittipong Chaiyasit, Thailand Markets Editorกองบรรณาธิการ PipDig
หน้านี้เป็นฉบับภาษาไทย เขียนขึ้นจากข้อเท็จจริงชุดเดียวกับฉบับภาษาอังกฤษ ไม่ใช่คำแปล อ่านฉบับภาษาอังกฤษ
- Quest PharmaTech said Dr. Madi Madiyalakan will retire on November 23, 2026.
- Quest PharmaTech said Jeffrey Shon will become CEO on November 23, 2026.
- Quest PharmaTech said its AGM will be held on November 23, 2026 at its corporate offices in Edmonton.
- Quest PharmaTech said it has a 26.6% ownership interest in OQPBIOM Inc..
Leadership change
Quest PharmaTech said Dr. Madi Madiyalakan will retire on November 23, 2026, and Jeffrey Shon will become CEO that day.
Meeting and holding
The company said its AGM is set for November 23, 2026, at its corporate offices in Edmonton.
Quest PharmaTech also disclosed a 26.6% ownership interest in OQPBIOM Inc.
ที่มา: GlobeNewswire,